🔴 Connect Biopharma is trading 5.29% down in after-hours trading — catalyst remains unclear

Connect Biopharma is trading 5.29% down at $1.25 in after-hours trading, with the catalyst unclear.

• It declined from the September 21 regular-session close of $1.32.
• No verified company-specific announcement or late-breaking event explaining the after-hours decline was identified.
• Investor sentiment may reflect disappointment over September 15 rademikibart asthma-trial results; the primary endpoint missed statistical significance despite positive secondary data. The broader market was strongly positive on September 21, making a market-wide risk-off explanation unlikely; recheck for delayed disclosures.